Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Notice of Knight Therapeutics' First Quarter 2025 Results Conference Call
-
Azucar Announces the Option of Three Projects in Nevada, USA from Almadex Minerals
-
Almadex Announces Option-Joint Venture Agreement on Three Nevada Properties with Azucar Minerals Ltd.
-
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates
-
Mighties Named Best Organic Healthy Drink for Kids by NewsWatch Magazine in 2025
-
United Community Banks, Inc. Announces Completion of Merger With ANB Holdings, Inc., The Parent of American National Bank
-
Altimmune to Present at Upcoming EASL International Liver Congress™ 2025
-
Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC
-
Digi Power X Maintains Strong Cash and Crypto Position with Debt-Free Operations and Reports April 2025 Production Results
-
Portillo’s Celebrates Italian Beef Day Throughout May with Free Sandwiches, Citywide Surprises and a Meaty Makeover with the Chicago Transit Authority
-
Prelude Therapeutics to Participate in Citizens Life Sciences Conference
-
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
-
Laureate Education Reports Financial Results For the First Quarter Of 2025
-
Hubbell Reports First Quarter 2025 Results
-
SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results
-
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025
-
Nexxen Announces April 2025 Share Repurchase Program Summary
-
Gain Therapeutics to Participate at The Citizens Life Sciences Conference
-
Miss America 2025 Abbie Stockard to Be Honored at Claire’s Place Foundation’s Clairity Ball 2025 – Casino Royale
-
Draganfly and Autonome Labs Announce Teaming Agreement to Deliver UAV-Based Demining Mesh Deployment Solution
-
Flow Capital Announces 2024 Annual Financial Results
-
HII Reports First Quarter 2025 Results
-
WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration
-
DTE Energy reports first quarter accomplishments, investments and earnings
-
Little Tikes® Becomes the Playground Super Hero with New Justice League™-Themed Toys
-
Altisource Announces First Quarter 2025 Financial Results
-
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
-
Crane NXT Completes Acquisition of De La Rue Authentication Solutions
-
Transaction in Own Shares
-
Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
-
Arvinas Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Eccogene Appoints Dr. Jai Patel as Chief Medical Officer
-
Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025
-
BioCryst Appoints Steve Frank to Board of Directors
-
Microbix Presenting at the 2025 Bloom Burton Conference
-
Sachem Capital Reports First Quarter 2025 Results
-
Enviri Corporation Reports First Quarter 2025 Results
-
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
-
Ligand to Participate in May Investor Conferences
-
Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates
-
First Commonwealth Completes Acquisition of CenterGroup Financial, Inc.
-
Rehmann Announces Business Combination with Martinet Recchia
-
Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
-
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
-
Lantronix to Report Fiscal 2025 Third Quarter Results on May 8, 2025
-
Atea Pharmaceuticals to Host Virtual HCV KOL Panel on May 14, 2025
-
BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
-
Orezone Provides Update on RCF Block Trade to Australian Funds
-
FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain
-
Enthusiast Gaming’s U.GG Expands Analytics Platform to Support Rainbow Six Siege
